John G. Gribben
Institute of Cancer
Barts and The London School of Medicine
London
UK
Name/email consistency: high
- Rediscovering alemtuzumab: current and emerging therapeutic roles. Gribben, J.G., Hallek, M. Br. J. Haematol. (2009)
- Molecular profiling in CLL. Gribben, J.G. Hematology. Am. Soc. Hematol. Educ. Program (2008)
- How I treat indolent lymphoma. Gribben, J.G. Blood (2007)
- Stem-cell transplantation in chronic lymphocytic leukaemia. Gribben, J.G. Best. Pract. Res. Clin. Haematol (2007)
- Autologous and allogeneic stem cell transplantations for poor-risk chronic lymphocytic leukemia. Gribben, J.G., Zahrieh, D., Stephans, K., Bartlett-Pandite, L., Alyea, E.P., Fisher, D.C., Freedman, A.S., Mauch, P., Schlossman, R., Sequist, L.V., Soiffer, R.J., Marshall, B., Neuberg, D., Ritz, J., Nadler, L.M. Blood (2005)
- Salvage therapy for CLL and the role of stem cell transplantation. Gribben, J.G. Hematology. Am. Soc. Hematol. Educ. Program (2005)